Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Sun Pharma and NIV join forces to fight zika, chikungunya & dengue

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases

Topics
Pharmaceuticals

Rakesh Rao  |  Mumbai 

Sun Pharma and the Pune-based National Institute of Virology (NIV), an institution of the Indian Council of Medical Research (ICMR), have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against zika, chikungunya and dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems. Candidate molecules with encouraging data will then be taken forward for commercial development. “Our agreement with NIV for developing drugs against zika, chikungunya and dengue ...

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, June 27 2017. 11:53 IST
RECOMMENDED FOR YOU

Sun Pharma and NIV join forces to fight zika, chikungunya & dengue

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases Sun Pharma and the Pune-based National Institute of Virology (NIV), an institution of the Indian Council of Medical Research (ICMR), have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against zika, chikungunya and dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems. Candidate molecules with encouraging data will then be taken forward for commercial development. “Our agreement with NIV for developing drugs against zika, chikungunya and dengue ... image
Business Standard
177 22

Sun Pharma and NIV join forces to fight zika, chikungunya & dengue

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases

Sun Pharma and the Pune-based National Institute of Virology (NIV), an institution of the Indian Council of Medical Research (ICMR), have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against zika, chikungunya and dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against zika, chikungunya and dengue in model systems. Candidate molecules with encouraging data will then be taken forward for commercial development. “Our agreement with NIV for developing drugs against zika, chikungunya and dengue ...

image
Business Standard
177 22